The role of arginine in thrombin receptor tethered-ligand peptide in intramolecular receptor binding and self-activation

被引:9
作者
Nose, T
Satoh, Y
Fujita, T
Ohno, M
Nakajima, M
Inoue, Y
Ogino, Y
Costa, T
Shimohigashi, Y [1 ]
机构
[1] Kyushu Univ, Fac Sci, Dept Chem, Biochem Lab, Fukuoka 8128581, Japan
[2] Green Cross Co, Div Res, Osaka 5731153, Japan
[3] Teikyo Univ, Sch Med, Dept Internal Med 3, Chiba 2990111, Japan
[4] Ist Super Sanita, Farmacol Lab, I-00161 Rome, Italy
关键词
D O I
10.1246/bcsj.71.1661
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Synthetic heptapeptide of the human thrombin receptor tethered-ligand peptide, H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-NH2 (SFLLRNP), activates fully the thrombin receptor without thrombin. The functional role of Arg-5 was examined using a series of analogs having amino acid substitutions at position 5 in this assays was to assess the abilities to hydrolyze phosphoinositide in human neuroblastoma SH-EP cells and to aggregate the human platelet. The replacement of Arg-5 by Ala reduced the activity (9% activity of the parent peptide) in the PI-turnover assay, and abolished completely the platelet aggregation activity. SFLL/Lys/NP was also active, but moderately. 36% in PI-turnover and 12% in platelet aggregation. These results indicated that the electrostatic interaction of the Arg-guanidino group is important for a peptide to interact with the receptor. When citrulline or glutamine was placed at position 5 instead of arginine, the resulting SFLL/citrulline/NP and SFLL/Gln/NP were found to be potent in both assays. Since citrulline and glutamine possess a side chain which can serve as hydrogen donor and/or acceptor, the receptor activation of these peptides appears to be due to hydrogen bonding at this position. The molecular mechanisms to explain both electrostatic and hydrogen-bonding interactions were postulated based on the structural modeling of seven-transmembrane domain thrombin receptor.
引用
收藏
页码:1661 / 1665
页数:5
相关论文
共 21 条
[1]  
BORIN G, 1977, INT J PEPT PROT RES, V10, P27
[2]   ESSENTIAL GROUPS IN SYNTHETIC AGONIST PEPTIDES FOR ACTIVATION OF THE PLATELET THROMBIN RECEPTOR [J].
CHAO, BH ;
KALKUNTE, S ;
MARAGANORE, JM ;
STONE, SR .
BIOCHEMISTRY, 1992, 31 (27) :6175-6178
[3]  
CORNISHBOWDEN A, 1984, EUR J BIOCHEM, V138, P9, DOI 10.1111/j.1432-1033.1984.tb07877.x
[4]  
DELANE A, 1978, AM J PHYSIOL, V4, pE97
[5]   REGULATION OF THROMBIN GENERATION AND FUNCTIONS [J].
FENTON, JW .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1988, 14 (03) :234-240
[6]   SPECIFICITY OF THE THROMBIN RECEPTOR FOR AGONIST PEPTIDE IS DEFINED BY ITS EXTRACELLULAR SURFACE [J].
GERSZTEN, RE ;
CHEN, J ;
ISHII, M ;
ISHII, K ;
WANG, L ;
NANEVICZ, T ;
TURCK, CW ;
VU, TKH ;
COUGHLIN, SR .
NATURE, 1994, 368 (6472) :648-651
[7]   Cellular consequences of thrombin-receptor activation [J].
Grand, RJA ;
Turnell, AS ;
Grabham, PW .
BIOCHEMICAL JOURNAL, 1996, 313 :353-368
[8]   MODEL FOR THE STRUCTURE OF BACTERIORHODOPSIN BASED ON HIGH-RESOLUTION ELECTRON CRYOMICROSCOPY [J].
HENDERSON, R ;
BALDWIN, JM ;
CESKA, TA ;
ZEMLIN, F ;
BECKMANN, E ;
DOWNING, KH .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 213 (04) :899-929
[9]  
HOLLENBERG MD, 1992, MOL PHARMACOL, V42, P186
[10]  
HUANG RS, 1991, J BIOL CHEM, V266, P18435